RXRA and metabolic syndrome: This RXRα phosphorylation site is found to be a MAPK/Erk consensus site [77], and as previously mentioned, elevated MAPK/Erk signaling is often associated with metabolic syndrome and insulin resistance, thus this provides a potential mechanistic link between metabolic syndrome and increased HCC risk.